244th ENMC international workshop: Newborn screening in spinal muscular atrophy May 10-12, 2019, Hoofdorp, The Netherlands

Affiliations

• ¹ Division of Child Neurology, Centre de Références des Maladies Neuromusculaires, Department of Pediatrics, University Hospital Liège & University of Liège, 4000 Belgium.
• ² Department of Biological Chemistry and Pharmacology, The Ohio State University, Columbus, OH, USA.
• ³ Department of Clinical and Molecular Genetics, University Hospital Valle Hebron, Medicine Genetics Group VHIR, Pso. Vall d' Hebron, 119-129, 08035 Barcelona, Spain. Electronic address: etizzano@vhebron.net.
• ⁴ Division of Child Neurology, Centre de Références des Maladies Neuromusculaires, Department of Pediatrics, University Hospital Liège & University of Liège, 4000 Belgium; MDUK Neuromuscular Center, Paediatric Department, University of Oxford, Oxford OX1 2JD, UK. Electronic address: lservais@chuliege.be.
• ⁵ University of Liege, Belgium.
• ⁶ Ohio State University, Columbus OH.
• ⁷ Bambino GesùChildren's Hospital, Rome, Italy.
• ⁸ Maastricht University, Maastricht, The Netherlands.
• ⁹ Ludwig-Maximilian University of Munich, Germany Francesco.
• ¹⁰ Catholic University of Sacred Heart, Rome, Italy.
• ¹¹ University of Warwick, Coventry, UK.
• ¹² University Hospital Valle Hebron, Barcelona, Spain.
• ¹³ MDUK Neuromuscular Center, University of Oxford, UK & University of Liege, Belgium.
• ¹⁴ Patient Advocacy Group, SMA Moscow, Russia.
• ¹⁵ Patient Advocacy Group, SMA Spain, Madrid, Spain.
• ¹⁶ Patient Advocacy Group, SMA France, Pessac, France.
• ¹⁷ Patient Advocacy Group, SMA Poland, Poland.
• ¹⁸ Muscular Dystrophy Association, Washington, D.C., USA.
• ¹⁹ Biogen, Boston, MA, USA.
• ²⁰ Roche Pharma Research and Early Development.
• ²¹ La Roche Ltd, Basel, Switzerland.
• ²² PerkinElmer Finland, Turku, Finland.
• ²³ Medical Affairs, London, UK; AveXis, a division of Novartis, Bannockburn, IL, USA.